Best Castleman Disease Hospitals in Turkey

Acibadem International Hospital offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 1989, the JCI accredited hospital is located in Istanbul, Turkey, with 112 beds, providing comprehensive care for local and international patients.

Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.

At Memorial Ankara Hospital, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 2014, the JCI accredited hospital is located in Ankara, Turkey, and has 230 beds.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.

Medipol Bahçelievler Hospital offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 2022, the JCI accredited hospital is situated in Istanbul, Turkey, with 441 beds, serving local and international patients.

Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.

Florence Nightingale Hospital provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 1989, the JCI accredited hospital is based in Istanbul, Turkey, with 804 beds and services for domestic and international patients.

The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.

Antalya Anadolu Hastanesi provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 2006, the accredited hospital is based in Antalya, Turkey, with 114 beds and services for domestic and international patients.

The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.

At Liv Hospital Ulus, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 2013, the JCI accredited hospital is located in Istanbul, Turkey, and has 154 beds.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.

With advanced haematology and oncology infrastructure, Medicana International Ankara Hospital offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 2008, the JCI accredited hospital is located in Ankara, Turkey, and has 215 beds.

For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.

With advanced haematology and oncology infrastructure, Special Neolife Medical Center offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 2010, the JCI accredited hospital is located in Istanbul, Turkey, and it has adequate bed capacity.

For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.

With advanced haematology and oncology infrastructure, Medicana International Samsun Hospital offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 2011, the JCI accredited hospital is located in Samsun, Turkey, and has 249 beds.

For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.

Medicana International Istanbul provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 1992, the JCI accredited hospital is based in Istanbul, Turkey, with 186 beds and services for domestic and international patients.

The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.

Memorial Antalya Hospital offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 2010, the JCI accredited hospital is located in Antalya, Turkey, with 114 beds, providing comprehensive care for local and international patients.

Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.

At Medical Park Antalya Hospital, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 2008, the JCI accredited hospital is located in Antalya, Turkey, and has 228 beds.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.

VM Medical Park Ankara offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 2014, the JCI accredited hospital is located in Ankara, Turkey, with 327 beds, providing comprehensive care for local and international patients.

Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.

Bayindir Healthcare Group provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 1992, the JCI accredited hospital is based in Ankara, Turkey, with 153 beds and services for domestic and international patients.

The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.

With advanced haematology and oncology infrastructure, Acibadem University Hospital Atakent offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 2014, the JCI accredited hospital is located in Istanbul, Turkey, and has 278 beds.

For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.